arrow
M

Michaela Theilmann

Heidelberg University
H指数:20
被引数:2,189

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implementation of WHO-PEN interventions in Eswatini: an assessment of health equity and out-of-pocket expenditure for diabetes and hypertension care

在斯威士兰实施WHO-PEN干预措施:对糖尿病和高血压护理中的健康公平性和自付费用的评估

2026-03-260
OAAI
Enablers and barriers for scaling up non-communicable disease interventions across diverse global health contexts: a qualitative study using the Consolidated Framework for Implementation Research

非传染性疾病干预措施在多样化全球健康背景下的规模扩大:一项使用实施研究整合框架的定性研究

2025-12-090
OA
National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countries

来自62个中低收入国家的关于糖尿病降糖药物使用情况的全国性证据

2025-08-040
OAAI
Unintentional Injuries Requiring Medical Attention in Low-Income and Middle-Income Countries: Evidence from Nationally Representative surveys in 12 Countries

低收入和中等收入国家需要医疗干预的非故意伤害:来自12个国家代表性调查的证据

2025-06-100
OA
The prevalence of cardiovascular disease risk factors among adults living in extreme poverty

极端贫困地区成年人中心血管疾病危险因素的患病率

2024-03-130
PRE
Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countries

高血压护理级联并减少中低收入国家心血管疾病的不公平现象

2024-01-262
PRE
Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data

阿司匹林用于心血管疾病一级预防的全球患病率: 一项具有全国代表性的个人水平数据的横断面研究

2024-01-011
OAAI
Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey data

44个低收入和中等收入国家的糖尿病风险和糖尿病预防活动的提供: 全国代表性的个人水平调查数据的横断面分析

2023-10-017
OAAI
Diagnostictesting for hypertension, diabetes, and hypercholesterolaemia in low-income and middle-income countries: a cross-sectional study of data for 994185 individuals from 57 nationally representative surveys

低收入和中等收入国家的高血压,糖尿病和高胆固醇血症的诊断测试: 来自57个全国代表性调查的994185个人数据的横断面研究

2023-09-018
OAAI
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries

阿司匹林用于51个低、中、高收入国家的心血管疾病二级预防

2023-08-228
OA
Patterns of tobacco use in low and middle income countries by tobacco product and sociodemographic characteristics: nationally representative survey data from 82 countries

按烟草制品和社会人口特征分列的中低收入国家烟草使用模式: 来自82个国家的全国代表性调查数据

2022-08-3026
OAAI
Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data

42个低收入和中等收入国家糖尿病护理和控制的城乡差异: 全国代表性个体水平数据的横断面研究

2022-06-3019
OA
Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model

低收入和中等收入国家中糖尿病及其相关心血管危险因素的诊断、治疗和控制增加的估计效果: 微观模拟模型

2021-11-0129
OAAI
Targeting Hypertension Screening in Low- and Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 Countries

针对低收入和中等收入国家的高血压筛查: 对56个国家1.2万成年人的横断面分析

2021-07-064
OAAI
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults

55个低收入和中等收入国家的糖尿病治疗覆盖状况: 680个102成年人的全国代表性个人水平数据的横断面研究

2021-06-01115
OAAI
Variation in the Proportion of Adults in Need of Blood Pressure-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries A Cross-Sectional Study of 1 037 215 Individuals From 50 Nationally Representative Surveys
2021-03-0915
OA
Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries
2020-10-2092
OAAI